NO307460B1 - Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof - Google Patents

Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof

Info

Publication number
NO307460B1
NO307460B1 NO970437A NO970437A NO307460B1 NO 307460 B1 NO307460 B1 NO 307460B1 NO 970437 A NO970437 A NO 970437A NO 970437 A NO970437 A NO 970437A NO 307460 B1 NO307460 B1 NO 307460B1
Authority
NO
Norway
Prior art keywords
preparation
methods
optically active
active compounds
pharmaceutical mixture
Prior art date
Application number
NO970437A
Other languages
Norwegian (no)
Other versions
NO970437L (en
NO970437D0 (en
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO970437D0 publication Critical patent/NO970437D0/en
Publication of NO970437L publication Critical patent/NO970437L/en
Publication of NO307460B1 publication Critical patent/NO307460B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
NO970437A 1995-06-01 1997-01-31 Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof NO307460B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (3)

Publication Number Publication Date
NO970437D0 NO970437D0 (en) 1997-01-31
NO970437L NO970437L (en) 1997-02-20
NO307460B1 true NO307460B1 (en) 2000-04-10

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970437A NO307460B1 (en) 1995-06-01 1997-01-31 Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A0 (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
IL109144A (en) * 1993-03-29 2000-02-29 Zeneca Ltd Glycoprotein IIB/IIIA inhibiting 4-pyridylamino heterocyclic derivatives process for their preparation and pharmaceutical compositions containing them
NZ262942A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions

Also Published As

Publication number Publication date
CH691808A5 (en) 2001-10-31
AU710105B2 (en) 1999-09-16
IE960405A1 (en) 1996-12-11
AU5827296A (en) 1996-12-18
HU9700274D0 (en) 1997-04-28
AT406675B (en) 2000-07-25
EP0796247A1 (en) 1997-09-24
PL318440A1 (en) 1997-06-09
BE1009520A5 (en) 1997-04-01
GB2304340B (en) 1998-07-29
LU90008B1 (en) 1997-04-16
ITMI961113A1 (en) 1997-12-01
NL1003243C2 (en) 1996-12-04
FI970393A (en) 1997-01-30
MC2418A1 (en) 1997-05-23
KR100245957B1 (en) 2000-04-01
ATA900596A (en) 1999-12-15
NO970437L (en) 1997-02-20
DK10697A (en) 1997-04-01
JPH09512836A (en) 1997-12-22
SE9700203L (en) 1997-01-24
FI970393A0 (en) 1997-01-30
CA2194397A1 (en) 1996-12-05
HUP9700274A2 (en) 1999-06-28
IL118477A0 (en) 1996-09-12
ITMI961113A0 (en) 1996-05-31
SK13097A3 (en) 1997-08-06
KR970704689A (en) 1997-09-06
GB9627127D0 (en) 1997-02-19
GB2304340A (en) 1997-03-19
MX9700379A (en) 1997-04-30
WO1996038416A1 (en) 1996-12-05
ES2137886B1 (en) 2000-08-16
HUP9700274A3 (en) 2000-02-28
CZ26997A3 (en) 1997-08-13
SE510812C2 (en) 1999-06-28
SE9700203D0 (en) 1997-01-24
BR9606409A (en) 1997-09-30
GR1002702B (en) 1997-05-22
DE19680509T1 (en) 1997-12-04
NO970437D0 (en) 1997-01-31
NZ308597A (en) 1998-11-25
JP2885941B2 (en) 1999-04-26
ES2137886A1 (en) 1999-12-16
TR199700020T1 (en) 1997-04-22
IT1290839B1 (en) 1998-12-14

Similar Documents

Publication Publication Date Title
FI973278A (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical preparations containing them
NO975931D0 (en) Mixture for administration of drug
DK0826673T3 (en) Acetamide derivatives, processes for their preparation and medical preparations
NO996433L (en) New formulations of drugs, methods of preparation thereof and methods of use thereof
NO20002835L (en) 2-aryl-oxodihydropurine derivatives, process for the preparation of these medicinal preparations containing them, and intermediates therefor
NO973479L (en) Substituted heterocyclic compounds, method of preparation and pharmaceutical compositions containing the same
ATE221531T1 (en) CRYSTAL MODIFICATION OF CDCH, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
NO307707B1 (en) Spiroazabicyclic compounds, pharmaceutical preparations containing such compounds and their use
NO20001219D0 (en) Mixture for drug administration
PT1003478E (en) AQUOSOL AQUOSOL PREPARATIONS CONTAINING BIOLOGICALLY ACTIVE MACROMOLECULES AND PROCESS FOR THE PREPARATION OF THEIR RESPIRATORS
NO974572D0 (en) Cyclodextrin Compounds, Methods of Preparation and Use
NO994003L (en) Pharmaceutical mixture
FR2707882B1 (en) New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
NO984878D0 (en) Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters
NO305903B1 (en) Benzonitriles and benzofluorides, drugs comprising the compounds, pharmaceutical compositions containing the compounds, and use of the compounds for the preparation of pharmaceutical preparations
NO307510B1 (en) Bicyclic aromatic compounds, their use and pharmaceutical and cosmetic preparations thereof
DK132790D0 (en) ANTI-INFLAMMATORY AND ANALGETIC COMPOUNDS, PREPARATIONS THEREOF AND METHODS OF PREPARING AND USING THEREOF
NO980403D0 (en) Catalytic mixture and process for its preparation
NO965023L (en) Maltitol mixture and preparation thereof
NO930796D0 (en) GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
NO975634D0 (en) Stable pharmaceutical preparations containing tiludronate hydrates and process for the preparation of pharmaceutical preparations
FI973230A0 (en) New pharmaceutical formulation
DK0806949T3 (en) New pharmaceutical composition containing trimebutin and process for its preparation
BR9610851A (en) Compound compound preparation process medicine pharmaceutical composition and use of the compound
NO307460B1 (en) Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002